Probity Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Probity Advisors's GILD Position: Q3 2026 in Review
Probity Advisors reduced its Gilead Sciences (GILD) stake by 0.05% in Q3 2026, selling an estimated $842 and leaving 12,122 shares worth $1.81M. The position accounts for 0.26% of the portfolio, ranked #68.
Probity Advisors first reported a position in GILD in Q2 2020 and has held it in 24 quarters since. 2,328 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Probity Advisors held 12,122 shares of Gilead Sciences worth $1.81M as of Q3 2026.
- Probity Advisors sold 6 Gilead Sciences shares in Q3 2026, an estimated $842.
- Gilead Sciences made up 0.26% of Probity Advisors's portfolio in Q3 2026, its #68 holding.
- Probity Advisors first reported a position in Gilead Sciences in Q2 2020 and has held it in 24 quarters since.
- 2,328 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Probity Advisors's 13F filing for Q3 2026, filed 23 Oct 2026.